Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Timothy Devos, Quentin Van Thillo, Veerle Compernolle, Tomé Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, Lucie Seyler, Martial Moonen, Michel Moutschen, Niels Van Regenmortel, Kevin K. Ariën, Cyril Barbezange, Albrecht Betrains, Mutien Garigliany, Matthias M. Engelen, Iwein Gyselinck, Piet Maes, Alexander Schauwvlieghe, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt. Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma. Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021

Member's Comments

No comment yet.

Related content which might interest you: Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Relationship of serum immunoglobulines and IgG subclasses in previously healthy adult patients with community acquired pneumonia Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Detection of Mycoplasma pneumoniae IgA and IgM antibodies in adult patients hospitalized because of acute asthma exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Correlates of the SARS-CoV-2 Ag or Total Ig antibody levels with hematological parameters in Greek hospitalized COVID-19 patients. Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Management of COVID-19: Other drugs and convalescent plasma Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 SIT follow-up: Measurements of specific IgG and IgG4 serum levels Source: Eur Respir J 2002; 20: Suppl. 38, 507s Year: 2002 Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 Other drugs and convalescent plasma Source: Virtual Congress 2020 – Management Year: 2020 Impact of the presence of serum neutralising antibodies on recruitment into experimental rhinovirus infection studies in asthmatic subjects Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Seroprevalence of anti-SARS-CoV-2 IgG antibody in hospitalized patients: Results of the first hospital-based serosurvey from India Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Very high levels of serum immunoglobulin E (IgE): A clinical profile of 18 children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 There are no correlations between the level of serum antichlamidia antibodies and clinical course of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 Addition of convalescent plasma to systemic corticosteroids in early phase of COVID-19 Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Long-term treatment with monoclonal antibodies anti-IgE in severe asthma: Follow-up of ten patients Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Change of T2-markers in patients with severe uncontrolled asthma treated by monoclonal antibodies: 1 yr follow up Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021